Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Vikas Lifecare
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 134 | 118 | 99 | 116 | 99 | 132 | 92 | 135 | 118 | 135 | 92 | 141 | 97 |
| Expenses + | 129 | 117 | 96 | 114 | 104 | 128 | 92 | 136 | 121 | 158 | 98 | 259 | 127 |
| Operating Profit | 5 | 1 | 3 | 2 | -5 | 4 | -0 | -1 | -3 | -23 | -6 | -118 | -30 |
| OPM % | 3% | 1% | 3% | 2% | -5% | 3% | -0% | -1% | -3% | -17% | -6% | -83% | -31% |
| Other Income + | 1 | -32 | 12 | 7 | 3 | -2 | 2 | 3 | -1 | 21 | 133 | 1 | 1 |
| Interest | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 2 |
| Profit before tax | 3 | -32 | 13 | 8 | -3 | -1 | 0 | -1 | -7 | -5 | 125 | -120 | -33 |
| Tax % | -78% | -17% | 9% | 2% | 28% | 222% | 9,833% | -349% | 1% | -46% | 0% | -1% | -12% |
| Net Profit + | 6 | -27 | 12 | 8 | -4 | -2 | -3 | 2 | -7 | -3 | 125 | -119 | -29 |
| EPS in Rs | 0.04 | -0.19 | 0.08 | 0.05 | -0.02 | -0.01 | -0.02 | 0.01 | -0.04 | -0.02 | 0.67 | -0.64 | -0.16 |
Financials of Vikas Lifecare
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| Sales + | 75 | 301 | 476 | 446 | 480 | 466 |
| Expenses + | 67 | 302 | 464 | 442 | 488 | 642 |
| Operating Profit | 8 | -1 | 12 | 4 | -8 | -176 |
| OPM % | 10% | -0% | 2% | 1% | -2% | -38% |
| Other Income + | -3 | 44 | -28 | 20 | 6 | 156 |
| Interest | 5 | 2 | 2 | 3 | 5 | 6 |
| Depreciation | 1 | 2 | 3 | 4 | 7 | 7 |
| Profit before tax | -2 | 39 | -21 | 17 | -13 | -33 |
| Tax % | 133% | 26% | -27% | 21% | -15% | |
| Net Profit + | -4 | 29 | -16 | 13 | -11 | -26 |
| EPS in Rs | -0.03 | 0.26 | -0.11 | 0.09 | -0.06 | -0.15 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of Vikas Lifecare
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 66 | 110 | 144 | 165 | 186 | 186 |
| Reserves | 0 | 90 | 187 | 311 | 346 | 367 |
| Borrowings + | 42 | 23 | 30 | 34 | 77 | 97 |
| Other Liabilities + | 41 | 98 | 93 | 44 | 121 | 82 |
| Total Liabilities | 149 | 321 | 454 | 555 | 729 | 731 |
| Fixed Assets + | 12 | 28 | 47 | 56 | 61 | 52 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 3 | 84 | 77 | 183 | 54 | 376 |
| Other Assets + | 133 | 208 | 330 | 316 | 614 | 302 |
| Total Assets | 149 | 321 | 454 | 555 | 729 | 731 |
Financials of Vikas Lifecare
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | -8 | -15 | -112 | -42 | -222 |
| Cash from Investing Activity + | 12 | -37 | -36 | -91 | 106 |
| Cash from Financing Activity + | -4 | 59 | 151 | 137 | 108 |
| Net Cash Flow | -0 | 8 | 2 | 4 | -8 |
| Free Cash Flow | -9 | -28 | -130 | -51 | -234 |
| CFO/OP | -90% | 1,565% | -949% | -1,045% | 2,905% |
Financials of Vikas Lifecare
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 347 | 52 | 130 | 120 | 97 |
| Inventory Days | 156 | 36 | 10 | 8 | 4 |
| Days Payable | 216 | 84 | 48 | 13 | 47 |
| Cash Conversion Cycle | 287 | 4 | 92 | 115 | 54 |
| Working Capital Days | 270 | 12 | 85 | 141 | 85 |
| ROCE % | 19% | -7% | 4% | 0% |
Radiant Acemoney has a healthy order pipeline for the current and next quarters, with 60%-70% already in the order book. Key concall takeaways from Radiant…
Movement Hire volumes grew 8% in Q1 FY27, moving from 711,000 to 766,000 pallets. Key concall takeaways from Leap India Ltd's Q1 FY27 earnings call — and how…
170 crores to Rs. Key concall takeaways from Creative Newtech Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.
Long-term goal: Annual PAT growth of 30%-40%, improve EBIT margins, and achieve INR2,000 crores revenue with 4%-4.5% EBIT margin in future years. Key concall…